Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Ophthalmol. 2024 Jun 1;72(6):849-855. doi: 10.4103/IJO.IJO_1864_23. Epub 2024 Mar 8.
To study the outcomes of balloon dacryoplasty (BD) or (BDCP) in children with persistent congenital nasolacrimal duct obstruction (pCNLDO) by using new and reused balloon catheters.
Our retrospective analysis focused on managing pCNLDO by using the BD or BDCP technique. The study included children aged >1 year to <12 years who underwent single or multiple probings before. Our specific lacrimal workup included a detailed history and examination, as published earlier. We used conventional, straight, 2 mm × 13 mm/3 mm × 15 mm lacrimal balloons (FCI, Ophthacath). We have described a technique to use the same catheter for three BD procedures (1 new + 2 reuse). The outcomes were categorized as complete success, partial success, and failure. The minimum follow-up of each child was 6 months.
We analyzed 64 children (89 eyes) with a mean age of 58 months (15-132 months). All children (100%) had epiphora with discharge and positive FDDT. All children underwent BD under general anesthesia - new balloons in 59 eyes and reused balloons in 30 eyes. The balloons were plasma sterilized akin to vitrectomy cutters and tubings of phaco machines. We noted three leaks from reused balloons (2 from the balloon tip and 1 from the plastic hub). At a mean follow-up of 14.5 months, complete success was noted in 77 eyes (86.5%) (52 new and 25 reuse), while 8 eyes had partial success (8.9%) (4 new and 4 reuse). Failure of BD was noted in four eyes (4.5%) (3 new and 1 reuse). None had significant complications with new or reused balloons.
BD or BDCP is a quick, safe, easy, and effective procedure that resolves pCNLDO symptoms satisfactorily. Carefully reusing a conventional balloon catheter is possible with comparable efficacy and no additional complications in pCNLDO.
研究使用新的和重复使用的球囊导管对持续性先天性鼻泪管阻塞（pCNLDO）患儿进行球囊扩张术（BD）或（BDCP）的治疗效果。
我们的回顾性分析集中在使用 BD 或 BDCP 技术来治疗 pCNLDO。研究对象为年龄大于 1 岁且小于 12 岁的患儿，这些患儿在之前已经接受过一次或多次探通术。我们的具体泪道检查包括详细的病史和检查，如前所述。我们使用常规的、直的、2mm×13mm/3mm×15mm 的泪道球囊（FCI，Ophthacath）。我们已经描述了一种技术，可以将同一条导管用于三次 BD 手术（1 次新的+2 次重复使用）。将治疗效果分为完全成功、部分成功和失败。每个患儿的最低随访时间为 6 个月。
我们分析了 64 名患儿（89 只眼），平均年龄为 58 个月（15-132 个月）。所有患儿（100%）均有溢泪伴分泌物，且 FDDT 阳性。所有患儿均在全身麻醉下接受 BD 治疗——59 只眼使用新球囊，30 只眼使用重复使用球囊。球囊采用类似于玻璃体切割器和白内障机的管的等离子体灭菌。我们注意到 3 个重复使用球囊出现漏液（2 个来自球囊尖端，1 个来自塑料座）。在平均 14.5 个月的随访中，77 只眼（86.5%）（52 只新的和 25 只重复使用）治疗完全成功，8 只眼治疗部分成功（8.9%）（4 只新的和 4 只重复使用），4 只眼治疗失败（4.5%）（3 只新的和 1 只重复使用）。新球囊和重复使用球囊均未出现明显并发症。
BD 或 BDCP 是一种快速、安全、简便、有效的方法，可满意地缓解 pCNLDO 症状。在 pCNLDO 中，仔细重复使用传统球囊导管是可行的，其疗效相当，且无额外并发症。
